Clinical Trial Update: A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial evaluating the investigational drug NNC0662-0419 in adults with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0662-0419

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED